Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.

  • Carl Borrebaeck
Publishing year: 2015
Language: English
Pages: 1409-1410
Publication/Series: Expert Review of Molecular Diagnostics
Volume: 15
Issue: 11
Document type: Journal article (comment)
Publisher: Future Drugs Ltd

Abstract english

Interview with Professor Carl Borrebaeck DSc by Claire Raison (Commissioning Editor) Professor Carl Borrebaeck DSc, is the Director of CREATE Health (Lund, Sweden), a translational cancer center, previous Vice President of Lund University and specializes in immunotechnology, diagnostics and treatments for cancer. He has had remarkable success in co-founding collaborative working groups and related spin-out companies based in Lund. Professor Borrebaeck also serves as a member of the editorial advisory board for Expert Review of Molecular Diagnostics. Here, Professor Borrebaeck talks to Expert Review of Molecular Diagnostics about his experience and what is next for cutting-edge technology in cancer diagnostics.


  • Cancer and Oncology


  • ISSN: 1744-8352
Carl B
Carl Borrebaeck
E-mail: carl.borrebaeck [at]


Department of Immunotechnology



Create Health

+46 46 222 96 13